|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS11416 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-SHIP1 |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human SHIP1 |
SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體說明書 英文名稱 Anti-SHIP1
中文名稱 SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體說明書
別 名 Inositol polyphosphate 5 phosphatase of 145kDa; 4; 5-trisphosphate 5-phosphatase 1; hp51CN; hSHIP; Inositol polyphosphate 5 phosphatase 145kDa; Inositol polyphosphate 5 phosphatase; Inositol polyphosphate 5 phosphatase D; Inositol polyphosphate-5-phosphatase of 145 kDa; INPP 5D; INPP5D; INPP5D protein; MGC104855; MGC142140; MGC142142; p150 ship; p150Ship; Phosphatidylinositol 3,4,5 trisphosphate 5 phosphatase 1; Phosphatidylinositol-3; SH2 containing inositol 5 phosphatase; SH2 containing inositol phosphatase isoform b; SH2 domain containing inositol 5' phosphatase 1; SH2 domain containing inositol phosphatase 1; SH2 domain-containing inositol phosphatase 1; SH2 domain-containing inositol-5''-phosphatase 1; SHIP 1; SHIP-1; SHIP1; SHIP1_HUMAN; Signaling inositol polyphosphate 5 phosphatase SIP 145; Signaling inositol polyphosphate 5 phosphatase SIP145; SIP 145; SIP-145; SIP145.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig, Cow, Horse
產(chǎn)品類型 一抗
研究領(lǐng)域 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 激酶和磷酸酶 t-淋巴細(xì)胞
蛋白分子量 predicted molecular weight: 133kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human SHIP1
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 SHIP1 is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and contains an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the plasma membrane is mediated by tyrosine phosphorylation in response to multiple cytokine and B and T cell receptor activation. At the plasma membrane, the protein hydrolyzes the 5' phosphate from phosphatidylinositol (3,4,5)-trisphosphate and inositol-1,3,4,5-tetrakisphosphate, thereby affecting multiple signaling pathways. Overall the protein functions as a negative regulator of myeliod cell proliferation and survival.
Function : Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity. Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6.
Subunit : Interacts with tyrosine phosphorylated forms of SHC1, DOK1, DOK3, PTPN11/SHP-2, SLAMF1/CD150. Interacts with PTPN11 in response to IL-3. Interacts with receptors EPOR, MS4A2/FCER1B and FCER1G, FCGR2A, FCGR2B and FCGR3. Interacts with GRB2 and PLCG1. Interacts with tyrosine kinases SRC and TEC. Interacts with FCGR2A, leading to regulate gene expression during the phagocytic process. Interacts with c-Met/MET (By similarity). Interacts with MILR1 (tyrosine-phosphorylated). Can weakly interact (via NPXY motif 2) with DAB2 (via PID domain); the interaction is impaired by tyrosine phosphorylation of the NPXY motif (By similarity).
Subcellular Location : Cytoplasm. Membrane; Peripheral membrane protein. Note=Translocates to the plasma membrane when activated, translocation is probably due to different mechanisms depending on the stimulus and cell type. Partly translocated via its SH2 domain which mediates interaction with tyrosine phosphorylated receptors such as the FC-gamma-RIIB receptor (FCGR2B) or CD16/FCGR3. Tyrosine phosphorylation may also participate in membrane localization (By similarity).
Tissue Specificity : Specifically expressed in immune and hematopoietic cells. Expressed in bone marrow and blood cells. Levels vary considerably within this compartment. Present in at least 74% of immature CD34+ cells, whereas within the more mature population of CD33+ cells, it is present in only 10% of cells. Present in the majority of T-cells, while it is present in a minority of B-cells (at protein level).
Post-translational modifications : Tyrosine phosphorylated by the members of the SRC family after exposure to a diverse array of extracellular stimuli such as cytokines, growth factors, antibodies, chemokines, integrin ligands and hypertonic and oxidative stress. Phosphorylated upon IgG receptor FCGR2B-binding.
Similarity : Belongs to the inositol 1,4,5-trisphosphate 5-phosphatase family.
Contains 1 SH2 domain.
Database links : UniProtKB/Swiss-Prot: Q92835.2
實驗流程：
全、新、優(yōu)、品、好四大特點：
SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
Anti-phospho-B-Raf (Ser445)/FITC 熒光素標(biāo)記磷酸化B-Raf抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-GRO Alpha/FITC 熒光素標(biāo)記兔抗生長調(diào)節(jié)致癌基因α抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh CIDEB 促進(jìn)凋亡基因抗體 規(guī)格 0.2ml
CCK8 (Cholecystokinin-8) 膽囊收縮素/縮膽囊素(八肽) 0.5mg
eIF4E 英文名稱： 真核翻譯起始因子4E抗體 0.1ml
Rhesus antibody Rh TNR/Tenascin-R 腱糖蛋白R抗體 規(guī)格 0.2ml
Anti-GRO Alpha/FITC 熒光素標(biāo)記兔抗生長調(diào)節(jié)致癌基因α抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Annexin V/PE 熒光素PE標(biāo)記兔抗人、大、小鼠、Annexin V抗體IgGMulti-class antibodies規(guī)格： 0.2ml
phospho-eIF4E(pSer209)(phospho-Eukaryotic translation initiation factor 4E) 磷酸化eIF-4E(Ser209)抗原Multi-class antibodies規(guī)格： 0.5mg
磷酸化活化復(fù)制因子2抗體 Anti-phospho-ATF2 0.1ml
ZAN 英文名稱： 透明帶黏附蛋白ZAN抗體 0.2ml
DOCK1 英文名稱： 細(xì)胞質(zhì)分裂付出蛋白1抗體 0.1ml
Rhesus antibody Rh phospho-EIF4B (Ser540) 磷酸化真核翻譯起始因子4B抗體 規(guī)格 0.1ml
phospho-eIF4E(pSer209)(phospho-Eukaryotic translation initiation factor 4E) 磷酸化eIF-4E(Ser209)抗原Multi-class antibodies規(guī)格： 0.5mg
CXCL14(CXC-chemokine ligand 16) CXC趨化因子14抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-BCHE (CT) 丁酰膽堿酯酶抗體(C端)Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh PHAP1 蛋酸酶2A抑制劑1抗體 規(guī)格 0.2ml
HBsAg 1:75 濃縮液 0.1ml 進(jìn)口分裝
UGT2B4 英文名稱： 尿苷二磷酸葡萄糖醛酸轉(zhuǎn)移酶2B4抗體 0.2ml
Complement C3 beta chain 英文名稱： 補(bǔ)體C3b抗體 0.1ml
Anti-BCHE (CT) 丁酰膽堿酯酶抗體(C端)Multi-class antibodies規(guī)格： 0.2ml
IL12B Protein Rat 重組大鼠 IL12B / IL-12B 蛋白 (His 標(biāo)簽)
小鼠腎小管上皮細(xì)胞完全培養(yǎng)基 100mL
TACSTD2 Others Mouse 小鼠 OP2 / TACSTD2 人細(xì)胞裂解液 (陽性對照)
S-180小鼠腹水瘤細(xì)胞 Mouse S-180 ascites tumor cells RPMI-1640(GIBCO)+10%FBS
CM-M047小鼠腸微細(xì)胞完全培養(yǎng)基100mL
TE-11(人細(xì)胞) 5×106cells/瓶×2 A-704(人細(xì)胞)
CM-M028小鼠食管平滑肌細(xì)胞完全培養(yǎng)基100mL
LMAN2L Others Human 人 LMAN2L 人細(xì)胞裂解液 (陽性對照)
球狀少突細(xì)胞培養(yǎng)基OsM
RL95-2細(xì)胞，人細(xì)胞 小鼠細(xì)胞(分泌促生長激素分泌激素),AtT-20細(xì)胞 人星形膠質(zhì)細(xì)胞HA
HFF-1(人成纖維細(xì)胞) 5×106cells/瓶×2
hMoCD14+-PB single donorPellet 人類外周血CD14+單核細(xì)胞團(tuán)塊單一來源，超純 > 1 mio.cells 人腦微內(nèi)皮細(xì)胞RNAHBMEC miRNA5 μg
SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體說明書 IL12B Protein Rat 重組大鼠 IL12B / IL-12B 蛋白 (His 標(biāo)簽)
小鼠腎小管上皮細(xì)胞完全培養(yǎng)基 100mL
TACSTD2 Others Mouse 小鼠 OP2 / TACSTD2 人細(xì)胞裂解液 (陽性對照)
S-180小鼠腹水瘤細(xì)胞 Mouse S-180 ascites tumor cells RPMI-1640(GIBCO)+10%FBS
CM-M047小鼠腸微細(xì)胞完全培養(yǎng)基100mL
TE-11(人細(xì)胞) 5×106cells/瓶×2 A-704(人細(xì)胞)
技術(shù)外包服務(wù):
★SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體說明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
